Oxygen-ozone therapy is at a cross-road

Autores/as

  • Velio Bocci Autor/a
  • Emma Borrelli Autor/a
  • Iacopo Zanardi Autor/a
  • Valter Travagli Autor/a

DOI:

https://doi.org/10.67442/ech8e572

Palabras clave:

Platelet-rich plasma, Platelet, Growth factors, ozone

Resumen

Oxygen-ozone therapy is slowly coming into age and it is being used in many Countries.
However, while the treatm ent of hernial disk b y s imply injecting a little vol um e of
gaseous O2-O3 ins ide t h e n u cleus pulpos u s is a great s u cc e ss , the us e o f the
so- called major oz o n a ted-autohemot h e rap y ( M-O3-AHT ) , consi sting of 200 mL
of autologous b l o o d treated with g a seous O2- O3 mixture and rapidly infused into
the donor, lags behind due to a number of reasons among which lack of standardization,
need of numerous treatment, lack of knowledge, skepticism and even denial. Skepticism,
which is fundamental to the scientific method, can be overcome only by showing the
validity of M-O3AHT in controlled and randomized clinical trials on specific diseases,
as correctly requested by the official Medicine. This paper aims to emphasize all the
problems plaguing this therapeutic modality and to suggest remedies to enhance its
progress and development.

Descargas

Publicado

2011-06-01

Número

Sección

Artículo Original

Cómo citar

Oxygen-ozone therapy is at a cross-road. (2011). Ozone Therapy Global Journal, 1(1), 74-86. https://doi.org/10.67442/ech8e572